Attributes | Values |
---|
rdf:type
| |
Description
| - A randomized Phase III trial was perfomed to determine if adding bexarotene to chemotherapy prolong survival Of NSCLC patients
- A randomized Phase III trial was perfomed to determine if adding bexarotene to chemotherapy prolong survival Of NSCLC patients (en)
- Třetí fáze randomizované studie klinického zkoušení posuzujícího kombinaci učinku chemoterapie v kombinaci s bexarotenem v léčbě nemalobuněčného karcinomu plic (cs)
|
Title
| - A randomized phase III trial comparing bexarotene / cisplatin / virorelbine versus cisplatin / virorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)
- A randomized phase III trial comparing bexarotene / cisplatin / virorelbine versus cisplatin / virorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC) (en)
- Třetí fáze randomizované klinické studie- aplikace bexarotenu / cisplatinu / vinorelbinu v chemoterapii pacientů s nemalobuněčným karcinomem plic (cs)
|
skos:prefLabel
| - A randomized phase III trial comparing bexarotene / cisplatin / virorelbine versus cisplatin / virorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)
- A randomized phase III trial comparing bexarotene / cisplatin / virorelbine versus cisplatin / virorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC) (en)
- Třetí fáze randomizované klinické studie- aplikace bexarotenu / cisplatinu / vinorelbinu v chemoterapii pacientů s nemalobuněčným karcinomem plic (cs)
|
skos:notation
| - RIV/00064211:_____/05:00000024!RIV06-MZ0-00064211
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00064211:_____/05:00000024
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - non-small cell lung cancer (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Journal of Clinical Oncology
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Zatloukal, Petr
- Ramlau, R.
- Dziewanowska, Z.
- Jassen, J.
- Marby, M.
- Negro-Vilar, A.
- Orlov, S.
- Rodrigues-Pereira, J.
- Schwarzenberger, S.
- Temperley, G. J.
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |